We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTS
426
DELISTED
Triple-S Management Corporation
GTS
| $4.61M | 0.03% |
243,635
-15,832
| -6% | -$330K |
|
427
Azenta
AZTA
$1.48B
| $4.59M | 0.03% |
394,926
-136,325
| -26% | -$1.67M |
|
|
IRS
428
IRSA Inversiones y Representaciones
IRS
$1.26B
| $4.59M | 0.03% |
241,952
+31,016
| +15% | +$508K |
|
|
CSH
429
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $4.56M | 0.03% |
195,696
+79,404
| +68% | +$1.76M |
|
430
Photronics
PLAB
$1.93B
| $4.55M | 0.03% |
535,706
+36,809
| +7% | +$310K |
|
431
SEI Investments
SEIC
$12.6B
| $4.54M | 0.03% |
102,934
-287,989
| -74% | -$12.1M |
|
432
Usana Health Sciences
USNA
$286M
| $4.53M | 0.03% |
81,504
+3,466
| +4% | +$178K |
|
433
Ciena
CIEN
$58.4B
| $4.51M | 0.03% |
+233,800
| New | +$4.66M |
|
434
WaFd
WAFD
$2.75B
| $4.49M | 0.03% |
205,850
-136,545
| -40% | -$2.88M |
|
|
PHH
435
DELISTED
PHH Corporation
PHH
| $4.49M | 0.03% |
185,686
-43,501
| -19% | -$1.05M |
|
436
Johnson & Johnson
JNJ
$625B
| $4.48M | 0.03% |
+44,500
| New | +$4.53M |
|
437
Northwest Bancshares
NWBI
$2.28B
| $4.45M | 0.03% |
375,118
-180,852
| -33% | -$2.15M |
|
|
TDAY
438
USA Today Co
TDAY
$1.06B
| $4.42M | 0.03% |
184,525
+113,824
| +161% | +$2.64M |
|
|
WW
439
DELISTED
WW International
WW
| $4.38M | 0.03% |
626,860
+586,275
| +1,445% | +$8.65M |
|
|
CHS
440
DELISTED
Chicos FAS, Inc.
CHS
| $4.37M | 0.03% |
246,986
+71,264
| +41% | +$1.24M |
|
|
AZPN
441
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $4.34M | 0.03% |
112,852
+32,836
| +41% | +$1.26M |
|
|
EA
442
DELISTED
Electronic Arts
EA
| $4.32M | 0.03% |
73,377
+43,859
| +149% | +$2.36M |
|
443
Trinity Industries
TRN
$2.38B
| $4.3M | 0.03% |
168,141
-985,933
| -85% | -$21.6M |
|
|
TWX
444
DELISTED
Time Warner Inc
TWX
| $4.29M | 0.03% |
+50,746
| New | +$4.22M |
|
|
BWLD
445
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $4.27M | 0.03% |
+23,571
| New | +$4.37M |
|
446
iShares MSCI Brazil ETF
EWZ
$8.95B
| $4.25M | 0.03% |
135,600
+69,376
| +105% | +$2.36M |
|
|
DF
447
DELISTED
Dean Foods Company
DF
| $4.25M | 0.03% |
256,948
-56,792
| -18% | -$975K |
|
448
Calix
CALX
$2.39B
| $4.21M | 0.03% |
502,220
-5,292
| -1% | -$47.5K |
|
|
ACOR
449
DELISTED
Acorda Therapeutics
ACOR
| $4.21M | 0.03% |
1,054
+785
| +292% | +$3.6M |
|
|
KNGT
450
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $4.18M | 0.03% |
129,770
-21,323
| -14% | -$688K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.